Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for Symptomatic Leg Superficial Vein Thrombosis
NCT02123524Phase 3Completed
- Sponsor
- McMaster University
- Start
- Nov 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in superficial vein thrombosis (SVT), sponsored by McMaster University. Started Nov 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
superficial vein thrombosis (SVT)
Beyond the preview
Go deeper on NCT02123524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123524.